ArticleCell reports. Medicine2024

Potent human monoclonal antibodies targeting Epstein-Barr virus gp42 reveal vulnerable sites for virus infection.

Ge-Xin Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.